Title:
METHODS FOR THE ADMINISTRATION OF ILOPERIDONE
Document Type and Number:
WIPO Patent Application WO2006039663
Kind Code:
A3
Abstract:
The present invention relates to methods for the identification of genetic polymorphisms that may be associated with a risk for QT prolongation after treatment with iloperidone and related methods of administering iloperidone to patients with such polymorphisms.
Inventors:
WOLFGANG CURT D (US)
POLYMEROPOULOS MIHAEL H (US)
POLYMEROPOULOS MIHAEL H (US)
Application Number:
PCT/US2005/035526
Publication Date:
November 02, 2006
Filing Date:
September 30, 2005
Export Citation:
Assignee:
VANDA PHARMACEUTICALS INC (US)
WOLFGANG CURT D (US)
POLYMEROPOULOS MIHAEL H (US)
WOLFGANG CURT D (US)
POLYMEROPOULOS MIHAEL H (US)
International Classes:
C12Q1/68; A61K38/00; A61K49/00; C07H21/04; C12M1/34; G01N33/53
Foreign References:
| US20020127561A1 | 2002-09-12 | |||
| US20030144220A1 | 2003-07-31 |
Other References:
JAIN K.K.: "An assessment of iloperidone for the treatment of schizophrenia", EXPERT OPINION ON INVESTIGATIONAL DRUGS, vol. 9, no. 12, 2000, pages 2935 - 2943, XP008092743
Download PDF: